These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1697660

  • 41. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
    Mota A, Bento A, Peñalva A, Pombo M, Dieguez C.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648
    [Abstract] [Full Text] [Related]

  • 42. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
    Peñalva A, Burguera B, Casabiell X, Tresguerres JA, Dieguez C, Casanueva FF.
    Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
    [Abstract] [Full Text] [Related]

  • 43. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A, Girelli A, Doga M, Bodini C, Bossoni S, Romanelli G, Wehrenberg WB.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [Abstract] [Full Text] [Related]

  • 44. [Effect of sex on the increase of GH induced by galanin, alone or in combination with GHRH with or without pyridostigmine in pubescent subjects].
    Guzzaloni G, Grugni G, Ardizzi A, Moro D, Calò G, Morabito F.
    Minerva Endocrinol; 1996 Jun; 21(2):53-7. PubMed ID: 9026681
    [Abstract] [Full Text] [Related]

  • 45. Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans.
    Barbarino A, Corsello SM, Tofani A, Sciuto R, Della Casa S, Rota CA, Barini A.
    J Clin Endocrinol Metab; 1991 Jul; 73(1):75-8. PubMed ID: 2045474
    [Abstract] [Full Text] [Related]

  • 46. Interaction of salbutamol and galanin on both basal and growth hormone releasing hormone-stimulated growth hormone secretion in humans.
    Arvat E, Ramunni J, Gianotti L, Di Vito L, Maccario M, Camanni F, Ghigo E.
    J Endocrinol Invest; 1995 May; 18(5):324-8. PubMed ID: 7594218
    [Abstract] [Full Text] [Related]

  • 47. Blindness impairs plasma growth hormone response to L-dopa but not to arginine.
    Bellastella A, Parlato F, Sinisi AA.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):856-8. PubMed ID: 2318945
    [Abstract] [Full Text] [Related]

  • 48. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J, Müller OA, Schopohl J, von Werder K.
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [Abstract] [Full Text] [Related]

  • 49. Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans.
    Ghigo E, Arvat E, Gianotti L, Ramunni J, Maccario M, Camanni F.
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):799-802. PubMed ID: 8033372
    [Abstract] [Full Text] [Related]

  • 50. Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients.
    Borges MH, Castro RC, Kater CE, Lengyel AM.
    Braz J Med Biol Res; 1993 Nov; 26(11):1191-200. PubMed ID: 7907904
    [Abstract] [Full Text] [Related]

  • 51. Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans.
    Mazza E, Ghigo E, Boffano G, Valetto M, Maccario M, Arvat E, Bellone J, Procopio M, Müller EE, Camanni F.
    Eur J Pharmacol; 1994 Mar 11; 254(1-2):17-20. PubMed ID: 8206111
    [Abstract] [Full Text] [Related]

  • 52. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
    Lima L, Arce V, Diaz MJ, Tresguerres JA, Devesa J.
    J Clin Endocrinol Metab; 1993 Feb 11; 76(2):439-44. PubMed ID: 8094392
    [Abstract] [Full Text] [Related]

  • 53. The role of the cholinergic pathway in growth hormone feedback.
    Kelijman M, Frohman LA.
    J Clin Endocrinol Metab; 1991 May 11; 72(5):1081-7. PubMed ID: 1902484
    [Abstract] [Full Text] [Related]

  • 54. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F, Peñalva A, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1993 Apr 11; 76(4):819-23. PubMed ID: 8473389
    [Abstract] [Full Text] [Related]

  • 55. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    Jaffe CA, DeMott-Friberg R, Barkan AL.
    J Clin Invest; 1996 Feb 15; 97(4):934-40. PubMed ID: 8613546
    [Abstract] [Full Text] [Related]

  • 56. Effects of sex and age on pyridostigmine potentiation of growth hormone-releasing hormone-induced growth hormone release.
    Corsello SM, Tofani A, Della Casa S, Rota CA, Sciuto R, Colasanti S, Barini A, Barbarino A.
    Neuroendocrinology; 1992 Aug 15; 56(2):208-13. PubMed ID: 1407375
    [Abstract] [Full Text] [Related]

  • 57. A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging.
    Ghigo E, Goffi S, Arvat E, Imperiale E, Boffano GM, Valetto MR, Mazza E, Santi I, Magliona A, Boghen MF.
    J Endocrinol Invest; 1992 Oct 15; 15(9):665-70. PubMed ID: 1479149
    [Abstract] [Full Text] [Related]

  • 58. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
    Peñalva A, Carballo A, Pombo M, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1993 Jan 15; 76(1):168-71. PubMed ID: 8421084
    [Abstract] [Full Text] [Related]

  • 59. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
    Maccario M, Procopio M, Grottoli S, Oleandri SE, Razzore P, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1995 Dec 15; 80(12):3774-8. PubMed ID: 8530634
    [Abstract] [Full Text] [Related]

  • 60. Growth hormone responses to pyridostigmine in normal adults and in normal and short children.
    Ghigo E, Mazza E, Imperiale E, Molinatti P, Bertagna A, Camanni F, Massara F.
    Clin Endocrinol (Oxf); 1987 Dec 15; 27(6):669-73. PubMed ID: 3331977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.